Healthy Technology Act of 2025

2/5/2025, 1:08 AM
Referred to the House Committee on Energy and Commerce.
Bill 119 hr 238, also known as the "Artificial Intelligence and Machine Learning Practitioner Act," aims to amend the Federal Food, Drug, and Cosmetic Act to allow artificial intelligence and machine learning technologies to be recognized as practitioners eligible to prescribe drugs. This recognition would be contingent upon authorization by the relevant state and approval, clearance, or authorization by the Food and Drug Administration (FDA).

The bill seeks to clarify the legal status of artificial intelligence and machine learning technologies in the healthcare industry, specifically in the realm of prescribing medication. By allowing these technologies to be considered practitioners, the bill aims to streamline and enhance the prescription process, potentially improving patient care and outcomes.

In addition to addressing the role of artificial intelligence and machine learning technologies in prescribing medication, the bill also includes provisions for other purposes related to healthcare and technology. The overall goal of the bill is to modernize and update existing regulations to better accommodate the use of advanced technologies in the healthcare field. Overall, Bill 119 hr 238 represents a significant step towards integrating artificial intelligence and machine learning technologies into the healthcare system, with the potential to revolutionize the way medication is prescribed and administered.
Congress
119

Number
HR - 238

Introduced on
2025-01-07

# Amendments
0

Sponsors
+5

Variations and Revisions

1/7/2025

Status of Legislation

Bill Introduced
Introduced to House
House to Vote
Introduced to Senate
Senate to Vote

Purpose and Summary

Referred to the House Committee on Energy and Commerce.
Bill 119 hr 238, also known as the "Artificial Intelligence and Machine Learning Practitioner Act," aims to amend the Federal Food, Drug, and Cosmetic Act to allow artificial intelligence and machine learning technologies to be recognized as practitioners eligible to prescribe drugs. This recognition would be contingent upon authorization by the relevant state and approval, clearance, or authorization by the Food and Drug Administration (FDA).

The bill seeks to clarify the legal status of artificial intelligence and machine learning technologies in the healthcare industry, specifically in the realm of prescribing medication. By allowing these technologies to be considered practitioners, the bill aims to streamline and enhance the prescription process, potentially improving patient care and outcomes.

In addition to addressing the role of artificial intelligence and machine learning technologies in prescribing medication, the bill also includes provisions for other purposes related to healthcare and technology. The overall goal of the bill is to modernize and update existing regulations to better accommodate the use of advanced technologies in the healthcare field. Overall, Bill 119 hr 238 represents a significant step towards integrating artificial intelligence and machine learning technologies into the healthcare system, with the potential to revolutionize the way medication is prescribed and administered.
Alternative Names
Official Title as IntroducedTo amend the Federal Food, Drug, and Cosmetic Act to clarify that artificial intelligence and machine learning technologies can qualify as a practitioner eligible to prescribe drugs if authorized by the State involved and approved, cleared, or authorized by the Food and Drug Administration, and for other purposes.

Comments

Recent Activity

Latest Action1/7/2025
Referred to the House Committee on Energy and Commerce.